FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

JUBLPHARMA

685.45
-0.35 (-0.05%)
Updated 12:44 30/07 IST

JUBLPHARMA Buy or Sell - FrontPage Forums

7 Users have submitted 7 trade ideas of Rs. 1,075,520 for JUBLPHARMA
Disclaimer
100% Bullish
0% Bearish

JUBLPHARMA Buy or Sell - Brokerage Reports

No. of reports in last year
4
No. of analysts
3
Average Consensus Forecast
791.75
Consensus Potential
3.72%
See JUBLPHARMA Share Price Targets >>

JUBLPHARMA Ratings

Long term JUBLPHARMA rating by FrontPage users
4.3/5 (4 Ratings)
Find answers to all your questions on live JUBLPHARMA message board: Is JUBLPHARMA buy or sell? Should I buy JUBLPHARMA shares? Why are JUBLPHARMA shares falling? Should I invest in JUBLPHARMA stock?

  1. Home
  2. JUBLPHARMA Forum

JUBLPHARMA Share Price Discussion

S
Reputation: 189 • Yesterday 3:06 AM

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹679.1
Price@Trade
₹679.1
Target Price
₹800
Stop Price
₹655
Valid Till
Aug 27, 2021 3:20 AM
Margin
₹135,820 approx for 200 Qty
Status
Active
Like
Reply
swap_vert
Trade
T
Reputation: 37,026 • Jul 24 3:28 AM

Result Highlights
Reliance Industries Ltd.: Net Revenue at Rs. 144372.0 crore, +58.2% YoY and -6.8% QoQ. EBITDA at Rs. 23368.0 crore, +38.5% YoY and +0.1% QoQ. EBITDA Margin at 16.2%, -231 bps YoY and +111 bps QoQ. Net Profit at Rs. 13806.0 crore, +4.2% YoY and -7.9% QoQ.
JSW Ste...
Read more...
2
Reply (2)
See all replies
Dilip K Patil @dilipkpatil
Jul 24 4:34 AM

Results aacha hai ya nahi ye kaise judge kare kohi bhi company ka ya dekha na jaruri hai ie- EBTA net profits year to year groww
TradeAdda @nishantshah91
Jul 24 4:36 AM

Majorly judged upon performance YoY QoQ and also agains analyst estimates and management commentry.

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹714.5
Price@Trade
₹715
Target Price
₹718
Stop Price
₹713.2
Valid Till
Jul 23, 2021 3:20 AM
Margin
₹714,500 approx for 1000 Qty
Status
Exited
Exit Price
₹713
Net P&L
-₹1,500 (-0.21%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 23 8:04 AM

Update
Trade Entered
Entry Price
₹714.5
Ganesh @ganesh-rknnTlrYu
Jul 23 8:11 AM

Update
Exited
Exit Price
₹713
Net P&L
-₹1,500 (-0.21%)

#JUBLPHARMA : Nippon Life India trustee bought 1.07% stake in co during Q1.
Like
Reply

#JUBLPHARMA Roorkee plant gets Import Alert by US FDA (Negative)
Like
Reply

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹721.35
Price@Trade
₹721.35
Target Price
₹900
Stop Price
₹700
Valid Till
Aug 16, 2021 3:20 AM
Margin
₹36,067.5 approx for 50 Qty
Status
Stoploss Hit
Exit Price
₹700
Net P&L
-₹1,067.5 (-2.96%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 23 8:37 AM

Update
Stoploss Hit
Exit Price
₹700
O
Reputation: 16 • Jul 16 4:02 AM
Like
Reply
K
Reputation: 15,069 • Jul 15 12:03 PM

Alert!
Jubilant Pharma Roorkee plant gets Import Alert by US FDA #JUBLPHARMA
4
Reply
S
Reputation: 3,428 • Jul 15 4:40 AM
Like
Reply
J
Reputation: 0 • Jul 15 4:35 AM

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹730.5
Price@Trade
₹730.5
Target Price
₹1,000
Stop Price
₹700
Valid Till
Jul 15, 2022 3:20 AM
Margin
₹73,050 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹700
Net P&L
-₹3,050 (-4.18%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 15 9:00 AM

Update
Stoploss Hit
Exit Price
₹700
O
Reputation: 16 • Jul 14 4:40 AM
Like
Reply

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹755
Price@Trade
₹755.45
Target Price
₹1,000
Stop Price
₹700
Valid Till
Aug 13, 2021 3:20 AM
Margin
₹755,000 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
₹700
Net P&L
-₹55,000 (-7.28%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 14 3:45 AM

Update
Trade Entered
Entry Price
₹755
TrackerBot @trackerbot
Jul 15 9:00 AM

Update
Stoploss Hit
Exit Price
₹700
M
Reputation: 144 • Jul 13 5:15 AM

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹748.4
Price@Trade
₹748.4
Target Price
₹800
Stop Price
₹725
Valid Till
Aug 13, 2021 3:20 AM
Margin
₹74,840 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹725
Net P&L
-₹2,340 (-3.13%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 15 4:38 AM

Update
Stoploss Hit
Exit Price
₹725

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹756
Price@Trade
₹746.8
Target Price
₹7,560
Stop Price
₹725
Valid Till
Aug 12, 2021 3:20 AM
Margin
₹75,600 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹725
Net P&L
-₹3,100 (-4.1%)

Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 12 6:00 AM

Update
Trade Entered
Entry Price
₹756
TrackerBot @trackerbot
Jul 15 4:38 AM

Update
Stoploss Hit
Exit Price
₹725

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹732
Price@Trade
₹732
Target Price
₹1,000
Stop Price
₹650
Valid Till
Aug 9, 2021 3:20 AM
Margin
₹366,000 approx for 500 Qty
Status
Active
Like
Reply
swap_vert
Trade
J
Reputation: 0 • Jul 6 3:11 AM

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹735
Price@Trade
₹732.55
Target Price
₹1,000
Stop Price
₹650
Valid Till
Jul 6, 2022 3:20 AM
Margin
₹73,500 approx for 100 Qty
Status
Active
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 6 3:53 AM

Update
Trade Entered
Entry Price
₹735

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹746.05
Price@Trade
₹746.05
Target Price
₹900
Stop Price
₹700
Valid Till
Jun 24, 2022 3:20 AM
Margin
₹22,381.5 approx for 30 Qty
Status
Stoploss Hit
Exit Price
₹700
Net P&L
-₹1,381.5 (-6.17%)

Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 15 9:00 AM

Update
Stoploss Hit
Exit Price
₹700
Like
Reply

Type
Buy
Instrument
JUBLPHARMA
Entry Price
₹758
Price@Trade
₹757.95
Target Price
₹1,000
Stop Price
₹600
Valid Till
Jun 21, 2022 3:20 AM
Margin
₹151,600 approx for 200 Qty
Status
Active

Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jun 21 5:52 AM

Update
Trade Entered
Entry Price
₹758
4
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • JUBLPHARMA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization10,580.71
    Enterprise Value12,147.97
    Price to Earnings50.87
    Price to Book Value4.52
    Return on Capital Employed0.14
    Return on Equity0.12
    Face Value1
    Dividend YieldNA
  • JUBLPHARMA - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    5-Nov-20Nirmal BangBuy909
    5-Nov-20Prabhudas LilladherAccumulate752
    7-Sep-20ICICIdirect.comBuy1,060
    7-Sep-20Prabhudas LilladherSell446
    1-Feb-20Nirmal BangBuy792
    JUBLPHARMA Brokerage Price Target
  • JUBLPHARMA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 29674.6689.8672.1685.8
    Jul 28674.35674.9659.05671.55
    Jul 27699705663.95668.7
    Jul 26715715684694.35
    Jul 23725725690697.1
  • JUBLPHARMA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹716.01
    30 Day Moving Average₹724.34
    50 Day Moving Average₹763.34
    100 Day Moving Average₹818.33
    200 Day Moving Average₹790.19
  • JUBLPHARMA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue3,3062,491.220.33
    Operating Profit5393180.69
    Profit Before Tax368114.522.21
    Net Income26379.192.32
  • JUBLPHARMA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds2,3402,2490.04
    Total Liabilities2,5232,605-0.03
    Total Assets4,8644,8540
  • JUBLPHARMA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity558419.150.33
    Cash from Investing Activity-127-43.071.95
    Cash from Financing Activity-470-338.40.39
    Net Cash Flow-4037.69-2.06
  • JUBLPHARMA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.02
    Return on Equity0.120.04
    Return on Capital Employed0.140.08
  • JUBLPHARMA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.04
    3 Year CAGR Growth in Operating Profit128.73
    3 Year CAGR Growth in EBIDTANA
    3 Year CAGR Growth in Net Income0.28
    3 Yr CAGR Growth - Diluted EPS0.28
  • JUBLPHARMA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.05
    5 Year CAGR Growth in Operating Profit0.47
    5 Year CAGR Growth in EBIDTA0.46
    5 Year CAGR Growth in Net Income7.07
    3 Yr CAGR Growth - Diluted EPS7.07
  • JUBLPHARMA - Recent News

    keyboard_arrow_down
    NewsBot
    Mar 21 10:41 AM
    6 crore COVID-19 vaccine doses sent to 76 nations, 4.5 cr doses administered in India: Harsh Vardhan
    The Economic Times
    NewsBot
    Feb 23 5:56 AM
    Aon survey projects average pay hike of 7.7% in 2021
    The Economic Times
    NewsBot
    Feb 23 4:16 AM
    Telangana's aiming for $100 billion life sciences exports by 2030, says Minister KT Rama Rao
    The Economic Times
    NewsBot
    Feb 22 10:36 AM
    Kochi firm PNB Vesper Life Sciences completes phase 2 clinical trial of coronavirus drug
    The Economic Times
    NewsBot
    Feb 4 3:21 AM
    GameStop’s unraveling accelerates as Redditors pivot to Biotech
    The Economic Times
    NewsBot
    Nov 26, 2020 2:23 AM
    Jubilant Life Sciences raises Rs 90 crore through commercial papers
    Moneycontrol
    NewsBot
    Nov 26, 2020 10:06 AM
    Jubilant Life Sciences raises Rs 90 cr through commercial papers
    The Economic Times
    NewsBot
    Nov 12, 2020 9:43 AM
    Accumulate Jubilant Life Sciences; target of Rs 752: Prabhudas Lilladher
    Moneycontrol
    NewsBot
    Nov 10, 2020 5:48 AM
    Buy Jubilant Life Sciences; target of Rs 855: Motilal Oswal
    Moneycontrol
    NewsBot
    Nov 9, 2020 5:33 AM
    Buy Jubilant Life Sciences; target of Rs 850: ICICI Direct
    Moneycontrol
  • JUBLPHARMA - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020